Given the well-established role of HER3 in HER2-positive breast cancer progression and therapeutic resistance, it is conceivable to hypothesize that PHF8 potentially acts as a key downstream mediator of HER3 signaling as well. This evidence concerns the gene PHF8 and breast carcinoma.